Why the study?
Do serial determinations of serum glutamic oxalacetic transaminase (SGO-T) levels have diagnostic and prognostic significance in patients hospitalized with chest pain suggestive of acute myocardial infarction?
Do serial determinations of serum glutamic oxalacetic transaminase (SGO-T) levels have diagnostic and prognostic significance in patients hospitalized with chest pain suggestive of acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Serial determinations of SGO-T levels provide diagnostic and prognostic value in patients presenting with chest pain suggestive of acute myocardial infarction.
Clinical and experimental studies of acute myocardial infarction suggest that serum glutamic oxalacetic transaminase (SGO-T) levels may have both diagnostic and prognostic significance. The authors report their experience in 255 patients hospitalized because of chest pain strongly suggestive of acute myocardial infarction. The results of serial determinations are compared with the clinical data and the electrocardiographic findings. The data indicate that abnormally high levels have both diagnostic and prognostic significance.
No takes yet. Share an insight, caveat, or question.
Kattus et al. (1957) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: